Latest stories on OCUL
Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences
GlobeNewswire52 · neutralproduct/pr
Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity
Seeking Alpha64 · neutralgeneral
Ocular Therapeutix, Inc. (OCUL) Discusses Progress and Regulatory Update on AXPAXLI NDA Filing Transcript
Seeking Alpha58 · neutralproduct/pr
Ocular Therapeutix management to meet with Piper Sandler
The Fly53 · neutralgeneral
H.C. Wainwright reiterates Ocular Therapeutix stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
Barchart22 · bearishgeneral
OCULAR THERAPEUTIX, INC (OCUL) files 8-K
SEC 8-K50 · neutralgeneral
Ocular Therapeutix, Inc. (OCUL) Presents at American Academy of Ophthalmology Retina Subspeciality Day - Slideshow
Seeking Alpha52 · neutralproduct/pr
Ocular Therapeutix initiated with a Buy at UBS
The Fly64 · neutralanalyst
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Ocular Therapeutix, Inc. (OCUL) Presents at Euretina 2026 - Slideshow
Seeking Alpha55 · neutralproduct/pr
OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD
Stocktwits News32 · bearishproduct/pr
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
GlobeNewswire56 · neutralgeneral
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
StockTitan56 · neutralproduct/pr
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
Business Insider56 · neutralproduct/pr
OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs
Stocktwits News32 · bearishgeneral
Ocular Therapeutix falls -18.2%
The Fly32 · bearishgeneral
Ocular Therapeutix shares down 22% after 4D Molecular announces Phase 3 results
The Fly34 · bearishearnings
Ocular Therapeutix falls -18.1%
The Fly32 · bearishgeneral
Ocular Therapeutix management to meet with Piper Sandler
The Fly56 · neutralgeneral
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
Yahoo Finance63 · neutralanalyst
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral